Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial.

AIDS
Sarah B LorenzanaRochelle P Walensky

Abstract

To project the clinical and economic outcomes of a genotype assay for selection of third-line antiretroviral therapy (ART) in resource-limited settings, as per the planned international A5288 trial (MULTI-OCTAVE). We used the Cost-effectiveness of Preventing AIDS Complications (CEPAC)-International Model to compare three strategies for patients who have failed second-line ART in South Africa: sustained second-line: no genotype assay, all patients remain on second-line ART; A5288: genotype to determine the resistance profile and assign an appropriate regimen; or population-based third-line: no genotype, all patients switch to a potent third-line regimen. Model inputs are from published data in South Africa. Resistance profiles, ART regimens, and efficacy data were those used for trial planning. Projected life expectancy for sustained second-line, A5288, and population-based third-line are 61.1, 103.8, and 104.2 months. Compared to sustained second-line ($12 ,460), per person lifetime costs increase for the A5288 ($39, 250) and population-based ($44, 120) strategies. The incremental cost-effectiveness ratio of A5288, compared to sustained second-line, is $7500/year of life saved (YLS), and for population-based third-line, compare...Continue Reading

References

Jun 15, 1997·Annals of Internal Medicine·J W MellorsC R Rinaldo
Jul 17, 1999·Journal of Clinical Epidemiology·S B Cantor, T G Ganiats
Feb 27, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Scott A WegnerUNKNOWN RV-125 Centers for Education and Research on Therapeutics Study Team
Oct 27, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Suely H TuboiMauro Schechter
Jan 20, 2006·The New England Journal of Medicine·Joel E GallantUNKNOWN Study 934 Group
Jul 1, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Charles B HolmesElena Losina
Sep 15, 2006·The New England Journal of Medicine·Sue J GoldieKenneth A Freedberg
Aug 19, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Moses R KamyaUNKNOWN Academic Alliance for AIDS Care and Prevention in Africa
Mar 11, 2008·AIDS Research and Human Retroviruses·Sandra de MeyerMarie-Pierre de Béthune
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vincent C MarconiUNKNOWN South Africa Resistance Cohort Study Team
Apr 22, 2008·The Journal of Infectious Diseases·Rochelle P WalenskyUNKNOWN CEPAC-International Investigators
May 17, 2008·International Journal of STD & AIDS·Rebecca Hammond, Tubonye C Harry
Jul 11, 2008·PLoS Medicine·Olivia KeiserUNKNOWN Swiss HIV Cohort Study (SHCS) and the International Epidemiologic Databases to Evaluate AIDS in Southern Africa (IeDEA-SA)
Jul 25, 2008·The New England Journal of Medicine·David A CooperUNKNOWN BENCHMRK Study Teams
Jan 15, 2009·Bulletin of the World Health Organization·Macarthur CharlesDaniel W Fitzgerald
May 19, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Eran BendavidDouglas K Owens
Jul 22, 2009·Annals of Internal Medicine·Rochelle P WalenskyUNKNOWN CEPAC (Cost-Effectiveness of Preventing AIDS Complications)-International Investigators
Oct 6, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Carole L WallisWendy Stevens
Oct 10, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Y YazdanpanahUNKNOWN ANRS 139 TRIO Trial Group
Oct 23, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Steven G DeeksRichard D Moore
Dec 25, 2009·Antiviral Therapy·UNKNOWN Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study GroupMatthias Egger
Apr 17, 2010·AIDS·Richard A MurphyUNKNOWN South Africa Resistance Cohort Study Team

❮ Previous
Next ❯

Citations

May 25, 2013·The Journal of Infectious Diseases·Mina C HosseinipourJean B Nachega
Apr 17, 2013·The Pediatric Infectious Disease Journal·Andres GomilaMichael Tolle
Mar 4, 2015·Open Forum Infectious Diseases·Habib O RamadhaniWilliam C Miller
Jul 16, 2015·The Journal of Infectious Diseases·Anne DeracheDavid Katzenstein
Nov 19, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Paula M LuzA David Paltiel
Jul 31, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jennifer A ThompsonUNKNOWN Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team
Nov 10, 2018·The Cochrane Database of Systematic Reviews·Theresa AvesLawrence Mbuagbaw
Oct 20, 2018·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michelle MoorhouseFrancesca Conradie
Feb 13, 2018·Open Forum Infectious Diseases·Cleophas ChimbeteteOlivia Keiser
Nov 15, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carole L WallisJohn W Mellors
Feb 27, 2021·AIDS Patient Care and STDs·Anuradha SubramanianRajeshwari Krishnan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Julie H LevisonRochelle P Walensky
Journal of Acquired Immune Deficiency Syndromes : JAIDS
Rochelle P WalenskyCost-Effectiveness of Preventing AIDS Complications-International Investigators
Journal of Acquired Immune Deficiency Syndromes : JAIDS
April D KimmelCEPAC-International Investigators
© 2022 Meta ULC. All rights reserved